334 related articles for article (PubMed ID: 22701199)
1. Barrett's Esophagus: Emerging Knowledge and Management Strategies.
Bhardwaj A; McGarrity TJ; Stairs DB; Mani H
Patholog Res Int; 2012; 2012():814146. PubMed ID: 22701199
[TBL] [Abstract][Full Text] [Related]
2. The controversy regarding ablation for Barrett's esophagus without dysplasia.
Gaddam S; Muthusamy R; Sharma P
Curr Opin Gastroenterol; 2011 Jul; 27(4):368-73. PubMed ID: 21577102
[TBL] [Abstract][Full Text] [Related]
3. Low risk of adenocarcinoma and high-grade dysplasia in patients with non-dysplastic Barrett's esophagus: Results from a cohort from a country with low esophageal adenocarcinoma incidence.
Pereira AD; Chaves P
United European Gastroenterol J; 2016 Jun; 4(3):343-52. PubMed ID: 27403300
[TBL] [Abstract][Full Text] [Related]
4. Barrett's Registry Collaboration of academic centers in Ireland reveals high progression rate of low-grade dysplasia and low risk from nondysplastic Barrett's esophagus: report of the RIBBON network.
O'Byrne LM; Witherspoon J; Verhage RJJ; O'Brien M; Muldoon C; Ryan C; Buckley M; Murphy T; Reynolds R; Patchett S; Kay E; Azam H; Robb W; Arumugasamy M; Mathuna PM; Leyden J; Gargan S; Doherty G; Sheahan K; Collins C; Nath A; O'Sullivan J; Donohoe CL; Ravi N; O'Toole D; Reynolds JV
Dis Esophagus; 2020 Oct; 33(10):. PubMed ID: 32193532
[TBL] [Abstract][Full Text] [Related]
5. Screening and surveillance for Barrett's esophagus: current issues and future directions.
Choi SE; Hur C
Curr Opin Gastroenterol; 2012 Jul; 28(4):377-81. PubMed ID: 22508325
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Progression of Persistent Nondysplastic Barrett's Esophagus to Malignancy.
Peters Y; Honing J; Kievit W; Kestens C; Pestman W; Nagtegaal ID; van der Post RS; Siersema PD
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):869-877.e5. PubMed ID: 30213587
[TBL] [Abstract][Full Text] [Related]
7. Barrett's esophagus in 2016: From pathophysiology to treatment.
Martinucci I; de Bortoli N; Russo S; Bertani L; Furnari M; Mokrowiecka A; Malecka-Panas E; Savarino V; Savarino E; Marchi S
World J Gastrointest Pharmacol Ther; 2016 May; 7(2):190-206. PubMed ID: 27158534
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic ablation is a cost-effective cancer preventative therapy in patients with Barrett's esophagus who have elevated genomic instability.
Das A; Callenberg KM; Styn MA; Jackson SA
Endosc Int Open; 2016 May; 4(5):E549-59. PubMed ID: 27227114
[TBL] [Abstract][Full Text] [Related]
9. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.
Anaparthy R; Gaddam S; Kanakadandi V; Alsop BR; Gupta N; Higbee AD; Wani SB; Singh M; Rastogi A; Bansal A; Cash BD; Young PE; Lieberman DA; Falk GW; Vargo JJ; Thota P; Sampliner RE; Sharma P
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1430-6. PubMed ID: 23707463
[TBL] [Abstract][Full Text] [Related]
10. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.
Wani S; Falk G; Hall M; Gaddam S; Wang A; Gupta N; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Reddymasu S; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Lieberman DA; Sampliner RE; Sharma P
Clin Gastroenterol Hepatol; 2011 Mar; 9(3):220-7; quiz e26. PubMed ID: 21115133
[TBL] [Abstract][Full Text] [Related]
11. Minichromosomal Maintenance Component Complex 5 (MCM5) as a Marker of Barrett's Esophagus-Related Neoplasia: A Feasibility Study.
Everson M; Magee C; Alzoubaidi D; Brogden S; Graham D; Lovat LB; Novelli M; Haidry R
Dig Dis Sci; 2019 Oct; 64(10):2815-2822. PubMed ID: 30982210
[TBL] [Abstract][Full Text] [Related]
12. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
[TBL] [Abstract][Full Text] [Related]
14. Advances in the management of Barrett's esophagus and early esophageal adenocarcinoma.
Singh A; Chak A
Gastroenterol Rep (Oxf); 2015 Nov; 3(4):303-15. PubMed ID: 26486568
[TBL] [Abstract][Full Text] [Related]
15. Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.
Whiteman DC; Appleyard M; Bahin FF; Bobryshev YV; Bourke MJ; Brown I; Chung A; Clouston A; Dickins E; Emery J; Eslick GD; Gordon LG; Grimpen F; Hebbard G; Holliday L; Hourigan LF; Kendall BJ; Lee EY; Levert-Mignon A; Lord RV; Lord SJ; Maule D; Moss A; Norton I; Olver I; Pavey D; Raftopoulos S; Rajendra S; Schoeman M; Singh R; Sitas F; Smithers BM; Taylor AC; Thomas ML; Thomson I; To H; von Dincklage J; Vuletich C; Watson DI; Yusoff IF
J Gastroenterol Hepatol; 2015 May; 30(5):804-20. PubMed ID: 25612140
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Screening for Barrett's Esophagus.
Sami SS; Iyer PG
Curr Treat Options Gastroenterol; 2018 Mar; 16(1):1-14. PubMed ID: 29330747
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic therapy of esophageal premalignancy and early malignancy.
Nealis TB; Washington K; Keswani RN
J Natl Compr Canc Netw; 2011 Aug; 9(8):890-9. PubMed ID: 21900219
[TBL] [Abstract][Full Text] [Related]
18. Significantly lower annual rates of neoplastic progression in short- compared to long-segment non-dysplastic Barrett's esophagus: a systematic review and meta-analysis.
Chandrasekar VT; Hamade N; Desai M; Rai T; Gorrepati VS; Jegadeesan R; Sathyamurthy A; Sharma P
Endoscopy; 2019 Jul; 51(7):665-672. PubMed ID: 30939618
[TBL] [Abstract][Full Text] [Related]
19. Screening for Barrett's esophagus.
Zakko L; Lutzke L; Wang KK
Minerva Med; 2017 Feb; 108(1):28-42. PubMed ID: 27792223
[TBL] [Abstract][Full Text] [Related]
20. Management of low-grade dysplasia in Barrett's esophagus.
Wani S
Curr Opin Gastroenterol; 2012 Jul; 28(4):370-6. PubMed ID: 22508323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
